Today, we’re going on a journey to explore the estimated Morepen Lab Share Price Target for the years 2023 to 2050. We will use our Research and the company’s growth prospects to make a prediction. By the end of our journey, you will have a better understanding of the expected Morepen Lab Share Price Target.
Morepen Laboratories Limited is a leading pharmaceutical company in India that specializes in the manufacturing and marketing of bulk drugs, formulations, and diagnostic kits. The company was founded in 1984 and is headquartered in New Delhi, India.
Morepen Lab has manufacturing facilities in Himachal Pradesh and Baddi, India, and its products are sold in over 25 countries worldwide.
Morepen Lab has a diversified product portfolio that includes medical devices, formulations, and diagnostic kits. The company’s products are used in various therapeutic areas such as cardiology, diabetology, and respiratory care. Morepen Lab is known for its focus on innovation, research, and quality, which has helped it establish a strong brand reputation in the global pharmaceutical industry.
Morepen Lab is a public company and is listed on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE). The company’s CEO is Sushil Suri. Morepen Lab has consistently reported strong revenue and profit growth in the last few years, driven by its focus on innovation, quality, and compliance. The company’s expansion plans and strategic partnerships are also expected to drive its future growth.
Overview of Morepen Lab
| Name | Morepen Laboratories Limited |
| Symbol | MOREPENLAB |
| Industry | Pharmaceuticals |
| Founded | 1984 |
| CEO | Sushil Suri |
| Headquarters | New Delhi, India |
| Exchange | NSE, BSE |
| Country | India |
| Locations | Manufacturing facilities in Himachal Pradesh and Baddi, India |
| Website | morepen.com |
| Profile | Morepen_Laboratories |
We will analyze the performance of the company’s shares in recent times and provide you with a well-researched Morepen Lab Share price target for 2023, 2025, 2030 to 2050.
Keep an eye on Morepen Lab’s share price today with real-time updates, and examine its performance on the stock market through comprehensive charts that display the fluctuations in Morepen Lab’s stock price.
Additionally, we will also take into analyst recommendations from various brokerage firms, including target high price, target low price, mean recommendation, and key recommendation at the end of the article.
Above, the chart presents historical prices for Morepen Lab stock, illustrating its trending behavior. Below, the table provides detailed data on the stock’s open, high, low, and close prices, offering a comprehensive perspective for stock analysis.
Brokerage Firms
An effective method for evaluating the Morepen Lab share price Target is by examining research reports and analyses conducted by reputable financial institutions and brokerage firms.
Latest Broker Research Reports are not available…….
Fundamentals of Morepen Lab
The fundamental analysis of Morepen Lab Limited focuses on key factors to better understand the company’s valuation.
We will analyze the performance of the company’s shares in recent times and provide you with a well-researched Morepen Lab price target for 2023, 2025 to 2030, based on our Research knowledge and forecasting.
Our research suggests that the minimum target for Morepen Lab’s share price in 2023 is ₹50, while the maximum target is ₹60. The reason behind this forecast is the company’s strong financial performance in the last few quarters. In Q4’FY23, Morepen Lab reported a revenue growth of 26% YoY, driven by the strong sales of its medical devices and formulations.
The company’s EBITDA margin also improved to 18%, compared to 15% in the previous year. Moreover, Morepen Lab has a robust pipeline of products in the research and development stage, which is expected to drive its future growth.
In 2024, we expect Morepen Lab’s share price to reach a minimum target of ₹70 and a maximum target of ₹80. The reason behind this forecast is the company’s expansion plans and strategic partnerships. Morepen Lab has recently signed a licensing agreement with a leading pharmaceutical company to manufacture and market a new drug in India.
The company is also planning to set up a new manufacturing facility to increase its production capacity and meet the growing demand for its products.
Our research suggests that Morepen Lab’s share price will reach a minimum target of ₹100 and a maximum target of ₹120 in 2025. The reason behind this forecast is the company’s focus on innovation and research.
Morepen Lab has a dedicated research and development team that is working on developing new drugs and formulations to address unmet medical needs. The company has also filed several patents for its innovative products, which is expected to drive its future growth.
Our research suggests that Morepen Lab’s share price will reach a minimum target of ₹200 and a maximum target of ₹240 in 2027. The reason behind this forecast is the company’s strong financial performance and growth prospects. Morepen Lab has consistently reported strong revenue and profit growth in the last few years, driven by its focus on innovation, quality, and compliance. The company’s expansion plans and strategic partnerships are also expected to drive its future growth.
In 2030, we expect Morepen Lab’s share price to reach a minimum target of ₹300 and a maximum target of ₹360. The reason behind this forecast is the company’s long-term growth prospects and market trends. The global pharmaceutical industry is expected to grow at a CAGR of 6.5% between 2021 and 2028, driven by the increasing demand for innovative drugs and medical devices. Morepen Lab’s focus on innovation, research, and quality is expected to help it capitalize on this growth opportunity.
Our research suggests that Morepen Lab’s share price will reach a minimum target of ₹500 and a maximum target of ₹600 in 2035. The reason behind this forecast is the company’s strong brand reputation, diversified product portfolio, and growth prospects. Morepen Lab has a wide range of products in its portfolio, including medical devices, formulations, and diagnostic kits, which is expected to help it capture a larger market share in the future.
Our long-term forecast suggests that Morepen Lab’s share price will continue to grow at a steady pace, driven by its focus on innovation, research, and quality. We expect the company’s share price to reach a minimum target of ₹800 and a maximum target of ₹1000 in 2040, and a minimum target of ₹1500 and a maximum target of ₹2000 in 2050.
Analyst Recommendations
Morepen Lab Buy or Sell
Daily Low / High
How to Buy Morepen Lab Stock
- Click on the “Open an Account“
- Fill in the required details
- Complete the verifying your identity
- Login to Your Account
- Search for Morepen Lab
- Place an Order.
| Telegram Channel | 👉 Click Here ☑ |
| Facebook Page | 👉 Click Here ☑ |
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2023 | ₹50 | ₹60 |
| 2024 | ₹70 | ₹80 |
| 2025 | ₹100 | ₹120 |
| 2026 | ₹150 | ₹180 |
| 2027 | ₹200 | ₹240 |
| 2030 | ₹300 | ₹360 |
| 2035 | ₹500 | ₹600 |
| 2040 | ₹800 | ₹1000 |
| 2050 | ₹1500 | ₹2000 |
– As of 16 September 2023, the current share price of Morepen Lab is ₹37.75 Check out today’s current share price.
– Based on our analysis, the maximum share price target for Morepen Lab in 2023 could be ₹60.
– According to Google historical data, the price of Morepen Lab on 6 Jul 2001 was ₹94.90.
To stay updated with the latest information related to the stock market and receive live stock market updates, follow Sharedhan and stay connected with us. Check out Today’s Share Market Open or Closed India.
I would like to remind you that I am not authorized by SEBI to provide any financial advice or recommendations. As you know, Share price prediction is not an exact science, That’s why I am conducting in-depth research and using different AI tools to predict share prices. My purpose is only educational, and I am using AI to see what the future of the stock might look like.
Disclaimer– These Share Price Targets for “Morepen Lab Share Price Target” are only provided for informational purposes only. It does not constitute a recommendation to buy, sell, or hold Morepen Lab stock. Investors should conduct their own research and analysis and consult with financial experts before making any investment decisions— Sharedhan.com
